Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 27, Issue 4
Early experience with the FDA’s regulatory review of novel gene therapies
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
EBM analysis
General medicine
Early experience with the FDA’s regulatory review of novel gene therapies
Online download statistics by month:
Online download statistics by month: October 2021 to August 2023
Abstract
Full
Pdf
Oct 2021
2185
48
33
Nov 2021
1855
23
23
Dec 2021
429
13
7
Jan 2022
329
25
7
Feb 2022
283
10
5
Mar 2022
251
12
5
Apr 2022
155
12
4
May 2022
297
14
5
Jun 2022
187
10
4
Jul 2022
384
24
10
Aug 2022
510
33
22
Sep 2022
300
15
8
Oct 2022
209
8
6
Nov 2022
188
15
7
Dec 2022
198
6
2
Jan 2023
178
6
7
Feb 2023
193
10
10
Mar 2023
150
9
3
Apr 2023
195
1
3
May 2023
126
5
2
Jun 2023
105
3
3
Jul 2023
147
3
2
Aug 2023
102
2
1
Total
8956
307
179
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF